Latest AI and machine learning research in dementia for healthcare professionals.
BACKGROUND: Language is a valuable source of clinical information in Alzheimer's disease, as it declines concurrently with neurodegeneration. Consequently, speech and language data have been extensively studied in connection with its diagnosis.
BACKGROUND: In recent years, accumulating evidence has linked vitamin D deficiency to cognitive dysfunction and dementia. This study aimed at determining the relevance of serum 25-hydroxyvitamin D concentrations in mild cognitive impairment (MCI) and Alzheimer's disease (AD) in older Greek adults. It also examined whether the vitamin D level could be considered a predisposing factor for conversion...
Rivastigmine is a non-competitive reversible inhibitor of acetylcholinesterase which is approved as one of the fi rst-line treatment options for Alzhe...
Alzheimer's disease (AD) is a typical neurodegenerative disease, which is clinically manifested as amnesia, loss of language ability and self-care abi...
BACKGROUND: The development of diagnostic and prognostic tools for Alzheimer disease is complicated by substantial clinical heterogeneity in prodromal...
The current study focuses on the short-term effect of MARIO, a social robot, on quality of life, depression, and perceived social support in persons w...
Artificial intelligence (AI) shows promises in terms of diagnostic support on neuroimaging. We developed a software that predicts Alzheimer's disease ...
Using AI for dementia diagnosis is still in research stage, however some of the work points to the development of new medical devices. One is a voxel-...
For patients with dementia and their family, artificial intelligence (AI) has been utilized to support diagnosis and evaluation. In addition, communic...
Alzheimer's disease significantly affects the quality of life of patients. This paper proposes an approach to identify Alzheimer's disease based on tr...
Early prediction of diseased brain conditions is critical for curing illness and preventing irreversible neuronal dysfunction and loss. Generically re...
Alzheimer's disease (AD) is characterized by gradual neurodegeneration and loss of brain function, especially for memory during early stages. Regressi...
A crucial quest in neuroimaging is the discovery of image features (biomarkers) associated with neurodegenerative disorders. Recent works show that su...
BACKGROUND AND OBJECTIVES: Recent years have seen social robotic pets introduced as a means of treating behavioral and psychological symptoms of demen...
BACKGROUND: Recruiting patients for clinical trials of potential therapies for Alzheimer's disease (AD) remains a major challenge, with demand for tri...
BACKGROUND: Memory dysfunction is characteristic of aging and often attributed to Alzheimer's disease (AD). An easily administered tool for preliminar...
BACKGROUND: Recently, many studies have been carried out to detect Alzheimer's disease (AD) from continuous speech by linguistic analysis and modeling...
Machine learning (ML) algorithms have found increasing utility in the medical imaging field and numerous applications in the analysis of digital bioma...
BACKGROUND: Predicting clinical course of cognitive decline can boost clinical trials' power and improve our clinical decision-making. Machine learnin...
BACKGROUND: Alzheimer's disease and related dementias (ADRDs) are being diagnosed at epidemic rates, with incidence to triple from 35 to 115 million c...